Novavax 2024财年GAAP每股收益$(1.23)超过$(1.32)的预期,销售额$6.8216亿不及$6.8494亿预期

财报速递2025-02-27
Novavax(NASDAQ:NVAX)公布的季度亏损为每股$(1.23),高于分析师一致预期的$(1.32),超过预期6.82%。与去年同期每股亏损$(5.41)相比,这增加了77.26%。公司公布的季度销售额为$6.8216亿,低于分析师一致预期的$6.8494亿,低于预期0.41%。与去年同期$9.8371亿的销售额相比,下降了30.65%。

以上内容来自Benzinga Earnings专栏,原文如下:

Novavax (NASDAQ:NVAX) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.32) by 6.82 percent. This is a 77.26 percent increase over losses of $(5.41) per share from the same period last year. The company reported quarterly sales of $682.16 million which missed the analyst consensus estimate of $684.94 million by 0.41 percent. This is a 30.65 percent decrease over sales of $983.71 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法